ATE29108T1 - Reagierende polymere fuer haut- und durchhautbehandlung. - Google Patents

Reagierende polymere fuer haut- und durchhautbehandlung.

Info

Publication number
ATE29108T1
ATE29108T1 AT83830269T AT83830269T ATE29108T1 AT E29108 T1 ATE29108 T1 AT E29108T1 AT 83830269 T AT83830269 T AT 83830269T AT 83830269 T AT83830269 T AT 83830269T AT E29108 T1 ATE29108 T1 AT E29108T1
Authority
AT
Austria
Prior art keywords
skin
reactive polymers
cross
formulations
components
Prior art date
Application number
AT83830269T
Other languages
English (en)
Inventor
Bruno Snider
Original Assignee
Sogimi Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogimi Srl filed Critical Sogimi Srl
Application granted granted Critical
Publication of ATE29108T1 publication Critical patent/ATE29108T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4288—Polycondensates having carboxylic or carbonic ester groups in the main chain modified by higher fatty oils or their acids or by resin acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/36—Hydroxylated esters of higher fatty acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT83830269T 1982-12-17 1983-12-16 Reagierende polymere fuer haut- und durchhautbehandlung. ATE29108T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT24839/82A IT1153909B (it) 1982-12-17 1982-12-17 Polimeri reattivi per la cura di affezioni cutanee
EP83830269A EP0114581B1 (de) 1982-12-17 1983-12-16 Reagierende Polymere für Haut- und Durchhautbehandlung

Publications (1)

Publication Number Publication Date
ATE29108T1 true ATE29108T1 (de) 1987-09-15

Family

ID=11214896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83830269T ATE29108T1 (de) 1982-12-17 1983-12-16 Reagierende polymere fuer haut- und durchhautbehandlung.

Country Status (14)

Country Link
US (1) US4560555A (de)
EP (1) EP0114581B1 (de)
JP (1) JPS59172422A (de)
KR (1) KR840006906A (de)
AT (1) ATE29108T1 (de)
AU (1) AU2248383A (de)
CA (1) CA1244590A (de)
DE (1) DE3373171D1 (de)
DK (1) DK582183A (de)
IE (1) IE56380B1 (de)
IL (1) IL70471A (de)
IT (1) IT1153909B (de)
NZ (1) NZ206586A (de)
ZA (1) ZA839345B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727868A (en) * 1984-11-13 1988-03-01 Thermedics, Inc. Anisotropic wound dressing
US4880690A (en) * 1984-11-13 1989-11-14 Thermedics, Inc. Perfume patch
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
JPS61249474A (ja) * 1985-04-25 1986-11-06 サ−メデイクス　インコ−ポレイテド 異方性医用被覆材
US4752472A (en) * 1986-03-25 1988-06-21 Exovir, Inc. Cosmetic skin treatment useing cyanoacrylate polymer film
US4743632A (en) * 1987-02-25 1988-05-10 Pfizer Hospital Products Group, Inc. Polyetherurethane urea polymers as space filling tissue adhesives
ES2026990T3 (es) * 1988-01-07 1992-05-16 Exovir, Inc. Tratamiento cosmetico de la piel.
GB8815435D0 (en) * 1988-06-29 1988-08-03 Smith & Nephew Non autoadherent dressings
US4972848A (en) * 1989-08-23 1990-11-27 Medtronic, Inc. Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
IL94910A (en) * 1990-06-29 1994-04-12 Technion Research Dev Foundati Biomedical adhesive compositions
DE19654468C1 (de) 1996-12-27 1998-01-22 Lohmann Therapie Syst Lts Extrem flexibles, dermal oder transdermal wirkendes Pflaster und Verfahren zu seiner Herstellung
NZ509376A (en) * 1998-07-09 2003-10-31 Francis A Nardella Indole or carbazole derivatives for the treatment of chronic lyphocytic leukemia
US7129262B2 (en) * 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) * 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US6545034B1 (en) * 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7361680B2 (en) * 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6403063B1 (en) 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US7736661B1 (en) * 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
CA2448226A1 (en) * 2001-03-07 2002-09-19 The Procter & Gamble Company Topical composition comprising a 1, 2-heteroatom constituted diene cosmetic bonding agent
CA2448233A1 (en) 2001-03-07 2002-09-19 The Procter & Gamble Company Topical composition comprising a three membered cyclic compound-based cosmetic bonding agent
WO2002072061A2 (en) 2001-03-07 2002-09-19 The Procter & Gamble Company Topical composition comprising an aldehyde or ketone-based cosmetic bonding agent
EP1367990A2 (de) 2001-03-07 2003-12-10 The Procter & Gamble Company Kosmetische zusammensetzungen zur topischen anwendung enthaltend funktionalisierte acylierende agentien
CN1538834A (zh) 2001-03-07 2004-10-20 包括功能性烷基化化妆品键合剂的局部组合物
WO2002096372A2 (en) 2001-05-30 2002-12-05 The Procter & Gamble Company Topical composition comprising an activated, trans-structured cosmetic bonding agent
MXPA03010860A (es) 2001-05-30 2004-02-17 Procter & Gamble COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO SUSTITUIDO.
US6602496B2 (en) 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US6746667B2 (en) 2001-07-05 2004-06-08 Closure Medical Corporation Adhesive treatment for tinea pedis
US6767552B2 (en) 2001-07-05 2004-07-27 Closure Medical Corporation Adhesive treatment for oral fungal infection
US6942875B2 (en) * 2001-07-05 2005-09-13 Closure Medical Corporation Adhesive treatment for skin yeast infections
US6585967B2 (en) 2001-07-05 2003-07-01 Closure Medical Corporation Adhesive treatment for tinea cruris
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
US20060216267A1 (en) * 2002-08-20 2006-09-28 Kovacs Stephen G Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis
US7402323B2 (en) * 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
US7211599B2 (en) * 2002-09-19 2007-05-01 The Regents Of The University Of California Use of etodolac to treat hyperplasia
US7915247B1 (en) 2006-08-21 2011-03-29 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
US20080107743A1 (en) * 2006-11-02 2008-05-08 Akpharma Inc. Composition and method for enhancing skin cell growth, proliferation and repair
WO2008154141A2 (en) * 2007-05-22 2008-12-18 Prelief Inc. Compositions and methods for preventing, minimizing and healing skin irritation and trauma
US8771725B2 (en) * 2007-10-12 2014-07-08 Chesson Laboratory Associates, Inc. Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526224A (en) * 1967-06-08 1970-09-01 Johnson & Johnson Dressing
DE2105062C3 (de) * 1971-02-04 1980-01-24 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Überzügen unter Verwendung von Zweikomponenten-Polyurethanlacken
DE2304893B1 (de) * 1973-02-01 1974-03-14 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Überzügen
US4250267A (en) * 1977-11-10 1981-02-10 W. R. Grace & Co. Immobilized biological material

Also Published As

Publication number Publication date
DK582183D0 (da) 1983-12-16
KR840006906A (ko) 1984-12-04
EP0114581A1 (de) 1984-08-01
DK582183A (da) 1984-06-18
DE3373171D1 (en) 1987-10-01
AU2248383A (en) 1984-06-21
NZ206586A (en) 1987-07-31
ZA839345B (en) 1984-08-29
IT8224839A1 (it) 1984-06-17
CA1244590A (en) 1988-11-08
EP0114581B1 (de) 1987-08-26
IL70471A (en) 1987-10-20
IE832970L (en) 1984-06-17
IE56380B1 (en) 1991-07-17
IT8224839A0 (it) 1982-12-17
IT1153909B (it) 1987-01-21
US4560555A (en) 1985-12-24
JPS59172422A (ja) 1984-09-29

Similar Documents

Publication Publication Date Title
ATE29108T1 (de) Reagierende polymere fuer haut- und durchhautbehandlung.
NO166943C (no) Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider.
DE69529577T2 (de) Prophylaktische und therapeutische behandlung von haupt sensibilisierung und -reizung
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
AT368391B (de) Verwendung von vernetzten polymeren als verdickungsmittel zur herstellung von kosmetischen, pharmazeutischen und technischen praeparaten
ATE82133T1 (de) Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen.
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DK156778C (da) Homogent vandigt haar- og tekstilbehandlingsmiddel, fremgangsmaade til behandling af haar eller tekstilfibre med midlet samt midlets anvendelse
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
IE40860L (en) N- heterocyclylalkylbenzamides
AU497383B2 (en) Method and bandage for administering scopolamine transdermally
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE69826023D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
CA960924A (en) Penetrating treatment for wood plastic composites and treated composites
KR910005858A (ko) 지방산 요법
DK199881A (da) Analogifremgangsmaade til fremstilling af pharmakologisk aktive peptider
TW259710B (de)
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
PT65737B (en) Process for the preparation of disubstituted phenol ethersof 3-amino-2-hydroxypropane with cerebrovascular activity application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and applicationof these pharmaceutical compositions in the treatment of cerebrovascular insufficiency
EP0255224A3 (de) Cyclische und verbrückt cyclische Analoge von Somatostatin, verwendbar als analgetische Arzneimittel
ES2058555T3 (es) Medicamento para el tratamiento intralesional del carcinoma de celulas escamosas, con alfa-interferon humano recombinante.
SU460057A1 (ru) Способ лечени долгонезаживающих ран и зв,термических и лучевых поражений

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties